Proteostasis Therapeutics, Inc. Presents Promising Preclinical Data at the 27th Annual North American Cystic Fibrosis Conference

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, today announced the presentation of data on the Company’s lead preclinical candidates and their potential for use as combination therapies for cystic fibrosis (CF) at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.

Help employers find you! Check out all the jobs and post your resume.